Used in: Figure 2 and Table 4 from Thompson et al. (2011), Investigation of the Mode of Action Underlying the Tumorigenic Response Induced in B6C3F1 Mice Exposed Orally to Hexavalent Chromium; Figure 6 from Kopec et al. (2012), Genome-wide gene expression effects in B6C3F1 … Continue reading →
Used in: Figure 2 and Table 3 from Thompson et al. (2011) Investigation of the Mode of Action Underlying the Tumorigenic Response Induced in B6C3F1 Mice Exposed Orally to Hexavalent Chromium; Figure 5 from Thompson et al. (2013), Assessment of the mode of action underlying … Continue reading →
Used in: Figures 4, 6, and Tables 1, 2 from Thompson et al. (2011), Application of the U.S. EPA Mode of Action Framework for Purposes of Guiding Future Research: A Case Study Involving the Oral Carcinogenicity of Hexavalent Chromium; Figures 1, 4, 5, … Continue reading →
Used in: Figure 3 from Thompson et al. (2013), Assessment of the mode of action underlying development of rodent small intestinal tumors following oral exposure to hexavalent chromium and relevance to humans; Figure 9 from Kopec et al. (2012), Genome-wide gene expression effects in … Continue reading →
Used in: Table 2 from Thompson et al. (2012) Assessment of Cr(VI)-induced cytotoxicity and genotoxicity using high content analysis; Figure 7 from Thompson et al. (2013) Assessment of the mode of action underlying development of rodent small intestinal tumors following oral exposure to … Continue reading →
Used in: Figure 8 from Kopec et al. (2012) Genome-wide gene expression effects in B6C3F1 mouse intestinal epithelia following 7 and 90 days of exposure to hexavalent chromium in drinking water; Figure 2 and Tables 1 &2 of O’Brien et al . (2013) Assessment … Continue reading →
Used in: Figures 1, 3, S2, S3 and Tables 2, S2, S3 from Thompson et al. (2011), Investigation of the Mode of Action Underlying the Tumorigenic Response Induced in B6C3F1 Mice Exposed Orally to Hexavalent Chromium; Table 2 from Thompson et al. (2012) Comparison of … Continue reading →